Hypertonicity and Piezo1 Activation Enhance Radiosensitivity of B16 Melanoma
Biological and Pharmaceutical Bulletin · 04.07.2026 · 49 (7) · 1049-1059
DOI: 10.1248/bpb.b26-00214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 04.07.2026. Verfasst von Yusei Yagi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, J…. Hauptthemen laut MEDLINE: Ion Channels, Melanoma, Experimental, Radiation Tolerance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.
Zitieren
APA
Yagi, Y., Kitabatake, K., & Tsukimoto, M. (2026). Hypertonicity and Piezo1 Activation Enhance Radiosensitivity of B16 Melanoma. Biological and Pharmaceutical Bulletin, 49(7), 1049-1059. https://doi.org/10.1248/bpb.b26-00214
Vancouver
Yagi Y, Kitabatake K, Tsukimoto M. Hypertonicity and Piezo1 Activation Enhance Radiosensitivity of B16 Melanoma. Biological and Pharmaceutical Bulletin. 2026;49(7):1049-1059. doi:10.1248/bpb.b26-00214
BibTeX
@article{Yagi2026,
author = {Yagi, Yusei and Kitabatake, Kazuki and Tsukimoto, Mitsutoshi},
title = {Hypertonicity and Piezo1 Activation Enhance Radiosensitivity of B16 Melanoma},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
volume = {49},
number = {7},
pages = {1049--1059},
doi = {10.1248/bpb.b26-00214}
}
EUVIMED